| Description |
1 online resource |
| Series |
Nanotechnology science and technology |
|
Nanotechnology science and technology series.
|
| Contents |
MAGNETIC NANOPARTICLES -- MAGNETIC NANOPARTICLES -- CONTENTS -- PREFACE -- FORMULATIONS FOR LOCAL, MAGNETICALLY MEDIATED HYPERTHERMIA TREATMENT OF SOLID TUMORS -- ABSTRACT -- 1. INTRODUCTION: UNDERSTANDING THE COMPLEXITY OF HYPERTHERMIA -- 1.1. Biological and Clinical Rationale for Induced Hyperthermia -- 1.1.1. Heat Effects and Toxicity at Cellular Level -- Morphostructural Changes Induced by Heat -- Metabolic Effects of Heat -- Heat Cytotoxicity and Thermal Dosimetry -- Molecular Biology of Stress Responses: Heat Shock, Hypoxia and Connections |
|
1.2.1. Hyperthermia in Oncology Hyperthermia Treatment Modalities -- Hyperthermia and Solid Tumor Pathophysiology -- Hyperthermic Therapy Combinations, Emphasis on Embolization Procedures -- Hyperthermia and Immunological Considerations -- 1.2. Current Technical Status of Induced Hyperthermia -- 1.2.1. Physical Modalities for Induced Hyperthermia -- 1.2.2. Inductive Modalities -- 1.2.3. Magnetic Losses -- Hysteresis Losses -- Losses by Magnetic Relaxations -- 2. FORMULATIONS FOR LOCAL HYPERTHERMIA TREATMENT OF HARD TISSUE TUMORS |
|
2.1. Magnetic Ceramic, Glass and Glass-Ceramic Materials 2.2. Glass/Ceramic Particles and Microspheres -- 2.3. Magnetic Materials for Cementoplasty -- 3. FORMULATIONS AND MINIMALLY INVASIVE PROCEDURES FOR MAGNETICALLY MEDIATED LOCAL HYPERTHERMIA TREATMENT OF SOFT TISSUE TUMORS -- 3.1. Arterial Injections and Arterial Embolization Hyperthermia (AEH) -- 3.1.1. Microparticles -- 3.1.2. Formulation Forming-Depot -- 3.2. Intratumoral Direct Injection Hyperthermia (DIH) -- 3.2.1. Formulation Forming Depot -- 3.2.2. Formulations Forming Implants In Situ |
|
4. MAGNETIC LIPOSOMES AND LOCAL HYPERTHERMIA TREATMENT OF TUMORS 4.1. General Characteristics of Liposomes -- 4.2. Magnetoliposomes and Magnetically Induced Local Hyperthermia of Tumor -- 4.3. Immunoconjugated Magnetoliposomes for the Systemic Approach of Magnetically Mediated Hyperthermia of Solid Tumors -- 4.3.1. Magnetoliposomes Conjugated with Anti CA9 (Human MN) Antigen Antibodies -- 4.3.2. Magnetoliposomes Coupled with Anti-HER2 Antibodies -- Anti-HER2 Immunoconjugated Magnetoliposomes and Pharmaceutical Considerations Associated with Anti-HER2 Antibodies |
|
Anti-HER2 Immunoconjugated Magnetoliposomes and Micropharmacology Considerations Associated with Non Magnetic Anti-HER2 Immunoliposomes4.4. Cationic Magnetoliposomes in Bone Metastasis of Prostate Cancer Model -- 4.5. Neutral Magnetoliposomes: Targeting Draining Lymphatic Nodes for Magnetic Hyperthermia -- CONCLUSION -- ACKNOWLEDGMENTS -- 6. LIST OF ABBREVIATIONS, UNITS, NOTATIONS AND SYMBOLS -- REFERENCES -- ORGANIC BASED MAGNETIC NANOPARTICLES-POLYMERS AND VARIOUS CALIXARENE BASED MAGNETIC NANOPARTICLES -- ABSTRACT -- INTRODUCTION |
| Bibliography |
Includes bibliographical references and index |
| Notes |
Description based on print version record |
| Subject |
Magnetic nanoparticles.
|
|
Nanostructures -- Magnetic properties
|
|
Nanoparticles -- Magnetic properties
|
|
TECHNOLOGY & ENGINEERING -- Material Science.
|
|
Magnetic nanoparticles
|
| Form |
Electronic book
|
| Author |
Acklin, Beate
|
|
Lautens, Edon
|
| LC no. |
2019722613 |
| ISBN |
9781619424456 |
|
1619424452 |
|
